Loading organizations...
Hambrecht & Quist Capital Management, based in San Francisco, California, provided investment banking services with a focus on financing early-stage growth companies, pioneering innovative methods like OpenIPO auction technology and advocating for Regulation A+ exemptions. The firm specialized in identifying disruptive companies, helping them raise capital, and supporting early public offerings, ultimately providing billions in early growth capital to over 500 companies. Its notable portfolio included early investments in technology and biotech giants such as Apple, Google, Genentech, and Adobe Systems. Hambrecht & Quist went public in 1996 and was acquired by Chase Manhattan in 1999, but its legacy includes leveling the playing field for investors and issuers through its OpenIPO approach. The organization was founded in 1968 by William R. Hambrecht and George Quist.
Hambrecht & Quist Capital Management has 1 tracked investment across 1 company. The latest tracked deal is $6.3M Series A Extension in Neurovance in April 2014.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Apr 3, 2014 | Neurovance | $6.3M Series A Extension | — | TIM Barberich, GBS Venture Partners, H&Q Healthcare Investors, Novartis, State OF Wisconsin Investment Board, Venture Investors |